Hepion Pharmaceuticals, Inc. (HEPA)
OTCMKTS · Delayed Price · Currency is USD
0.0480
+0.00338 (7.58%)
At close: Apr 14, 2026
Hepion Pharmaceuticals Market Cap
Hepion Pharmaceuticals has a market cap or net worth of $518.5 thousand as of April 14, 2026. Its market cap has increased by 197.72% in one year.
Market Cap
518.50K
Enterprise Value
439.63K
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.05
Market Cap Chart
Since February 10, 2014, Hepion Pharmaceuticals's market cap has decreased from 13.86M to 518.50K, a decrease of -96.26%. That is a compound annual growth rate of -23.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 518.50K | -25.63% |
| Dec 31, 2025 | 697.22K | -78.69% |
| Dec 31, 2024 | 3.27M | -76.72% |
| Dec 29, 2023 | 14.05M | -38.61% |
| Dec 30, 2022 | 22.89M | -73.66% |
| Dec 31, 2021 | 86.90M | 23.90% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Iterum Therapeutics | 734.41K |
| SQZ Biotechnologies Company | 707.79K |
| Emmaus Life Sciences | 701.88K |
| Scorpius Holdings | 611.43K |
| Bio-Path Holdings | 588.56K |
| EV Biologics | 536.83K |
| Eloxx Pharmaceuticals | 424.01K |
| Innovation Pharmaceuticals | 423.01K |